• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of new gene therapy vectors and the preclinical cancer animal model system using common marmoset

Research Project

Project/Area Number 17016053
Research Category

Grant-in-Aid for Scientific Research on Priority Areas

Allocation TypeSingle-year Grants
Review Section Biological Sciences
Research InstitutionKyushu University

Principal Investigator

TANI Kenzaburo  Kyushu University, 生体防御医学研究所, 教授 (00183864)

Co-Investigator(Kenkyū-buntansha) NAKAZAKI Yukou  九州大学, 生体防御医学研究所, 助手 (00346850)
HISANO Terumasa  九州大学病院, 助手 (40380399)
UCHIMARU Kaoru  東京大学, 医科学研究所, 助教授 (60251203)
MIURA Ryuichi  東京大学, 医科学研究所 (00322074)
NAKAYAMA Masaharu  九州大学病院, 助教 (80363349)
KURITA Ryo  九州大学, 生体防御医学研究所, 助教 (90380526)
SATO Hiroki  東京大学, 医科学研究所, 助教 (50418654)
Co-Investigator(Renkei-kenkyūsha) UCHIMARU Kaoru  東京大学, 医科学研究所, 准教授 (60251203)
SATO Hiroki  東京大学, 医科学研究所, 助教 (50418654)
Project Period (FY) 2005 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥50,000,000 (Direct Cost: ¥50,000,000)
Fiscal Year 2009: ¥10,000,000 (Direct Cost: ¥10,000,000)
Fiscal Year 2008: ¥10,000,000 (Direct Cost: ¥10,000,000)
Fiscal Year 2007: ¥10,000,000 (Direct Cost: ¥10,000,000)
Fiscal Year 2006: ¥10,000,000 (Direct Cost: ¥10,000,000)
Fiscal Year 2005: ¥10,000,000 (Direct Cost: ¥10,000,000)
Keywordsコモンマーモセット / フィラデルフィア染色体陽性急性リンパ性白血病 / 顆粒系マクロファージコロニー刺激因子 / 免疫遺伝子治療 / ケモカイン / 麻疹ウイルス / エンテロウイルス / 成人T細胞性白血病・リンパ腫 / 顆粒球・マクロファージコロニー刺激因子 / 腎癌 / 腫瘍溶解性ウイルス療法 / HTLV-1 / 遺伝子治療 / RANTES / レンチウイルスベクター / センダイウイルスベクター / ロイコトリエン / BLT1ノックアウトマウス / bcr / abl融合遺伝子 / 白血病 / TARC / abl 融合遺伝子 / GM-CSF遺伝子導入腫傷ワクチン / アデノウイルスベクター / RENCA 細胞 / abl / GM-CSF / SAGE法 / ケモカイン分子 / VSV-Gシュードタイプレンチウィルスベクター / SEREX法 / TMF / scFvファージディスプレイライブラリー
Research Abstract

To develop new therapies for cancer, we have been involved in the development of new animal cancer models and new gene therapy methods. During the past 5 years, we could successfully develop human T-lymphotropic virus (HTLV)-1 carrier model in small monkey of common marmoset. This animal model will become very helpful to elucidate pathophysiology of human adult T-cell leukemia and to develop its new therapeutic modality. We also developed new oncolytic virus gene therapy methods using measles virus and enterovirus, and new immune gene therapy method using GM-CSF expressing carrier cells. We are now preparing the phase I clinical study using this new gene therapy method.

Report

(6 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • 2007 Annual Research Report
  • 2006 Annual Research Report
  • 2005 Annual Research Report
  • Research Products

    (80 results)

All 2010 2009 2008 2007 2006 2005 Other

All Journal Article (44 results) (of which Peer Reviewed: 12 results) Presentation (19 results) Book (10 results) Patent(Industrial Property Rights) (7 results) (of which Overseas: 1 results)

  • [Journal Article] Enhanced antitumor effects of an oncolytic measles virus vaccine strain expressing the wild-type N, P, L genes on human renal cell carcinoma2010

    • Author(s)
      Xin M, Nakamura T,, Tani, K., et. al.
    • Journal Title

      Mol Ther. 18(3)

      Pages: 544-51

    • Related Report
      2009 Final Research Report
  • [Journal Article] Curiel DT. A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo2009

    • Author(s)
      Thacker EE, Nakayama M, Tani K, et. al.
    • Journal Title

      Vaccine 27

      Pages: 7116-7124

    • Related Report
      2009 Final Research Report
  • [Journal Article] Developmentof monoclonal antibodies for analyzing immune and hematopoietic systems of common marmoset2009

    • Author(s)
      Kametani, Y., Suzuki, D., Tani, K., et. al.
    • Journal Title

      Exp Hematol 37

      Pages: 1318-1329

    • Related Report
      2009 Final Research Report
  • [Journal Article] Development of monoclonal antibodies for analyzing immune and hemato poietic systems of common marmoset2009

    • Author(s)
      Kametani, Y., Suzuki, D., Tani, K., et al.
    • Journal Title

      Exp Hematol 37

      Pages: 1318-1329

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A genetically engineered adenovirus vector targeted to CD-40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo2009

    • Author(s)
      Thacker EE, Nakayama M, Tani.K., et al.
    • Journal Title

      Vaccine 27

      Pages: 7116-7124

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Enhanced Antitumor Effects of an Oncolytic Measles Virus Vaccine Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma2009

    • Author(s)
      Xin M, Nakamura T, Tani.K., et al.
    • Journal Title

      Mol Ther (in press)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tumor growth suppression by adenovirus-mediated introduction of a cell growth suppressing gene tob in a pancreatic cancer model2009

    • Author(s)
      Yanagie, H., Tani, K., et.al.
    • Journal Title

      Biomed Pharmacother 63

      Pages: 275-286

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Non-transmissible SeV encoding GM-CSF is a novel and potent vector system to produce autologous tumor vaccines2008

    • Author(s)
      Inoue, H., Iga, H., Tani, K., et. al
    • Journal Title

      Cancer Science 99

      Pages: 2315-2326

    • Related Report
      2009 Final Research Report
  • [Journal Article] TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model2008

    • Author(s)
      Inoue, H., Iga, M., Tani, K., et. al.
    • Journal Title

      Cancer Immunol Immun 57

      Pages: 1399-1411

    • Related Report
      2009 Final Research Report
  • [Journal Article] Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autoloaous tumor vaccines2008

    • Author(s)
      Inoue, H.,Iga, M.,Tani, K., et.al.
    • Journal Title

      Cancer Sci 99

      Pages: 2315-2326

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model2008

    • Author(s)
      Inoue, H., Iga, M., Tani, K., et.al.
    • Journal Title

      Cancer Immunol Immun 57

      Pages: 1399-1411

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Construction of a high-performance human fetal liver-derived lentiviral cDNA library2008

    • Author(s)
      Kurita, R., Tani, K., et.al.
    • Journal Title

      Mol Cell Biochem 319

      Pages: 181-187

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] SF-1/Ad4BP transforms human bone marrow mesenchymal cells into steroedogenic cells.2008

    • Author(s)
      Tanaka, T・Tani, K., et. al.
    • Journal Title

      J Mol Endocrinol (in press)

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] TARC and RANTES Enhance Antitumor Immunity Induced by the GM-CSF-Transduced Tumor Vaccine in a Mouse Tumor Model.2008

    • Author(s)
      Inue, H.・Tani., K., et. al.
    • Journal Title

      Cancer Immunol Immun (in press)

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A Critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice2007

    • Author(s)
      Sun, X, m Somada, S., Tani, K., et. al.,, Podack, E., Yoshikai, Y.
    • Journal Title

      Gastroenterology 134(2)

      Pages: 447-458

    • Related Report
      2009 Final Research Report
  • [Journal Article] Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma2007

    • Author(s)
      Kudo S, Konda R, Tani K, et. al., T.
    • Journal Title

      Oncol Rep 18

      Pages: 785-791

    • Related Report
      2009 Final Research Report
  • [Journal Article] Epithelioid hemangioendothelioma presenting with severe myelofibrosis and a high serum hyaluronan level.2007

    • Author(s)
      Suehiro, Y.・Tani, K., et. al.
    • Journal Title

      Eur J Haematol 79

      Pages: 349-353

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renalcell carcinoma2007

    • Author(s)
      Kudo, S・Tani, K., et. al.
    • Journal Title

      Oncol Rep 18

      Pages: 785-791

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A Critical Role of CD30 Ligand/CD30 in Controlling Inflammatory Bowel Diseases in Mice2007

    • Author(s)
      Sun, X.・Tani, K., et. al.
    • Journal Title

      Gastroenterology 134

      Pages: 447-458

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Glasgow JN. An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice2007

    • Author(s)
      Nakayama, M, Tani K, et al.
    • Journal Title

      Virology (in press)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell apoptosis2006

    • Author(s)
      Tanaka, T., Okabe, T., Tani, K., et. al.
    • Journal Title

      Exp Hematol 34

      Pages: 1542-1552

    • Related Report
      2009 Final Research Report
  • [Journal Article] Meeting Report: Nonhuman Primates: Embryonic stem cells and transgenesis2006

    • Author(s)
      Horn, P.A., Tani, K., et. al.
    • Journal Title

      Cloning and Stem Cells 8

      Pages: 124-129

    • Related Report
      2009 Final Research Report
  • [Journal Article] Fhit modulates the DNA damage checkpoint response2006

    • Author(s)
      Ishii, H., Mimori, K., Tani, K., et. al.
    • Journal Title

      Cancer Res 66

      Pages: 11287-11292

    • Related Report
      2009 Final Research Report
  • [Journal Article] Tal1/scl gene transduction using a lentiviral vector stimulates highly efficient hematopoietic cell differentiation from common marmoset (Callithrix jacchus) ES cells2006

    • Author(s)
      Kurita, R., Sasaki, E., Tani, K., et. al.
    • Journal Title

      Stem Cells 24

      Pages: 2014-2022

    • Related Report
      2009 Final Research Report
  • [Journal Article] Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses2006

    • Author(s)
      Nakazaki, Y., Hase, H., Tani, K., et. al.
    • Journal Title

      Mol Ther 14

      Pages: 599-606

    • Related Report
      2009 Final Research Report
  • [Journal Article] a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate2006

    • Author(s)
      Kunisaki, R., Ikawa, S., Tani, K., et. al.
    • Journal Title

      J Gene Med. 8

      Pages: 1121-1130

    • Related Report
      2009 Final Research Report
  • [Journal Article] An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution inmice2006

    • Author(s)
      Nakayama M, Both GW, Tani, K., et. al.
    • Journal Title

      Virology 350

      Pages: 103-115

    • Related Report
      2009 Final Research Report
  • [Journal Article] Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase2006

    • Author(s)
      Nagano, K., Itagaki, C., Tani, K., et. al.
    • Journal Title

      Oncogene 25

      Pages: 493-502

    • Related Report
      2009 Final Research Report
  • [Journal Article] Antiangiogenic activity of BAI1 in vivo:implications for gene therapy of human glioblastomas2006

    • Author(s)
      Kang X., Xinru Xiao, Tani, K., et. al.
    • Journal Title

      Cancer Gene Ther 13

      Pages: 385-392

    • Related Report
      2009 Final Research Report
  • [Journal Article] Antiangiogenic activity of BAI1 in vivo : implications for gene therapy of human glioblastomas2006

    • Author(s)
      Kang, X., Tani K., et al.
    • Journal Title

      Cancer Gene Ther 13

      Pages: 385-392

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase.2006

    • Author(s)
      Nagano, K., Tani, K., et al.
    • Journal Title

      Oncogene 25

      Pages: 493-502

    • Related Report
      2006 Annual Research Report
  • [Journal Article] p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate2006

    • Author(s)
      Kunisaki, R., Tani.K., et al.
    • Journal Title

      J Gene Med 8

      Pages: 1121-1130

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses.2006

    • Author(s)
      Nakazaki, Y., Tani, K., et al.
    • Journal Title

      Mol Ther 14

      Pages: 599-606

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Tal1/scl gene transduction using a lentiviral vector stimulates highly efficient hematopoietic cell differentiation fromcommon marmoset (Callithrix jacchus) ES cells.2006

    • Author(s)
      Kurita, R., Tani, K., et al.
    • Journal Title

      Stem Cells 24

      Pages: 2014-2022

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Fhit Modulates the DNA Damage Checkpoint Response.2006

    • Author(s)
      Ishii, H., Tani, K., et al.
    • Journal Title

      Cancer Res 66

      Pages: 11287-11292

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Protective effect of irradiated renal carcinoma expressing hepatitis B surface antigen against renal-cell carcinoma-mediated tumors.2006

    • Author(s)
      Moon, Y, Tani K., et al.
    • Journal Title

      Cancer Biother Radiopharm 21

      Pages: 211-216

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase2006

    • Author(s)
      Nagano.K, Tani, K.et al.
    • Journal Title

      Oncogene 25

      Pages: 493-502

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Antiangiogenic activity of BAI1 in vivo : implications for gene therapy of human glioblastomas2006

    • Author(s)
      Kang, X., Tani, K.et al.
    • Journal Title

      Cancer Gene Ther (In press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice2006

    • Author(s)
      Nakayama, M., Tani, K.et al.
    • Journal Title

      J Virol (In press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] A novel role of CD30/CD30L signaling in the generation of long-lived memory CD8+T cells2005

    • Author(s)
      Nishimura H., Yajima T., Tani K., et. al.
    • Journal Title

      J. Immunol 175

      Pages: 4627-4634

    • Related Report
      2009 Final Research Report
  • [Journal Article] Establishment of novel embryonic stem cell lines derived from the common marmoset2005

    • Author(s)
      Sasaki, E., Hanazawa, K., Tani, K.
    • Journal Title

      Stem cells 23

      Pages: 1304-1313

    • Related Report
      2009 Final Research Report
  • [Journal Article] Sustained molecular remission by non-myeloablative stem cell transplantation after autologous hematopoietic stem cell transplantation in a patient with multiple myeloma.2005

    • Author(s)
      Nakashima, Y., Tani, K., et al.
    • Journal Title

      Leuk Lymphoma 46

      Pages: 1217-1222

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset (Callithrix jacchus)2005

    • Author(s)
      Sasaki, E., Tani, K.et al.
    • Journal Title

      Stem Cells 23

      Pages: 1304-1313

    • Related Report
      2005 Annual Research Report
  • [Journal Article] A novel role of CD30/CD30L signaling in the generation of long-lived memory CD8+T cells2005

    • Author(s)
      Nishimura, H., Tani, K.et al.
    • Journal Title

      J Immunol 175

      Pages: 4627-4634

    • Related Report
      2005 Annual Research Report
  • [Presentation] In vitro induction of the hematopoietic progenitor/stem cells from human ES cells2009

    • Author(s)
      Kurita, R., Kageyama, R., Tani. K.
    • Organizer
      ASGCT 12th annual meeting
    • Place of Presentation
      San Diego
    • Related Report
      2009 Final Research Report
  • [Presentation] Efficient Induction of Hematopoietic Progenitor/Stem Cell Differentiation by Lentiviral Gene Transduction of TAL1/SCL into Human ES Cells2009

    • Author(s)
      Miura, Y., Kurita, R., Tani. K.
    • Organizer
      51st ASH Annual Meeting and Exposition
    • Place of Presentation
      New Orleans
    • Related Report
      2009 Final Research Report
  • [Presentation] Expression Cloning of Genes Enabling Erythropoietin-Independent Erythropoiesis in Vitro2009

    • Author(s)
      Yokoo, T., Kurita, R., Tani. K.
    • Organizer
      51th ASH (American Society of Hematology) Annual Meeting and Exposition
    • Place of Presentation
      New Orleans, LA
    • Related Report
      2009 Final Research Report
  • [Presentation] Engineered measles virus MV-NPL as a novel oncolytic therapy2009

    • Author(s)
      Okazaki, T., Meng, X., Tani. K., et al
    • Organizer
      第15回日本遺伝子治療学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] MV-NPL, as a new therapeutic oncolytic measles virus candidate2009

    • Author(s)
      Okazaki, T., Meng, T., Tani., T., et al.
    • Organizer
      12th Annual Meeting of the American Society of Gene Therapy
    • Related Report
      2009 Final Research Report
  • [Presentation] 進行・再発固形腫瘍(消化器癌・肺癌)に対するCyclophosphamide(CY)併用新規腫瘍関連抗原由エピトープペプチドカクテルを用いた腫瘍特異的強化ワクチン療法の検討(第I相臨床試験)2009

    • Author(s)
      土方康基、伊賀睦了、谷憲三朗, 他
    • Organizer
      第106回日本内科学会総会
    • Place of Presentation
      東京
    • Related Report
      2009 Final Research Report
  • [Presentation] Blocking LT4 signaling maintains the in vivo antitumor effects of GM-CSF transduced tumor cells2008

    • Author(s)
      Nabeta, H., Inoue, H., Tani, K., et al.
    • Organizer
      Japan Society of Gene Therapy (JSGT) 14th Annual Meeting
    • Place of Presentation
      Sapporo
    • Year and Date
      2008-06-13
    • Related Report
      2009 Final Research Report
  • [Presentation] Gene Therapy in USA. Educational Seminar III.2008

    • Author(s)
      Tani, K.
    • Organizer
      Japan Society of Gene Therapy (JSGT) 14th Annual Meeting
    • Place of Presentation
      Sapporo
    • Year and Date
      2008-06-13
    • Related Report
      2009 Final Research Report
  • [Presentation] Gene therapy in USA2008

    • Author(s)
      Tani,K
    • Organizer
      JSGT 14th Annual Meeting
    • Place of Presentation
      札幌
    • Year and Date
      2008-06-13
    • Related Report
      2008 Annual Research Report
  • [Presentation] Enhanced antitumor immunity by adoptively transfused Sendai virus mediated GM-CSF transduced dendritic cells in LLC bearing mice2008

    • Author(s)
      Inoue, H., Iga, M., Tani, K., et al.
    • Organizer
      Japan Society of Gene Therapy (JSGT) 14th Annual Meeting
    • Place of Presentation
      Sapporo
    • Year and Date
      2008-06-12
    • Related Report
      2009 Final Research Report
  • [Presentation] Blocking LT4 signaling maintains the antitumor effect of GM-CSF in the tumor challenge model using BLT-1-/- mice2008

    • Author(s)
      Nabeta, H., Inoue, H., Tani, K., et al.
    • Organizer
      America Society of Gene Therapy (ASGT) 11h Annual Meeting
    • Place of Presentation
      Boston, USA
    • Year and Date
      2008-05-29
    • Related Report
      2009 Final Research Report
  • [Presentation] Dendritic Cells Transduced with Granulocyte Macrophage Colony Stimulating Factor mediated by Non-Transmissible Sendai Virus Induce Therapeutic Antitumor Immunity in LLC Bearing Mice2008

    • Author(s)
      Inoue, H., Iga, M., Tani, K., et.al.
    • Organizer
      ASGT 11th Annual. Meeting
    • Place of Presentation
      Boston
    • Year and Date
      2008-05-29
    • Related Report
      2008 Annual Research Report
  • [Presentation] Blocking LTB4 Signaling Maintains the Antitumor Effect of GM-CSF in the Tumor Challenge Model Using BLT-14-Mice2008

    • Author(s)
      Inoue, H., Iga, M., Tani, K., et.al.
    • Organizer
      ASGT 11th Annual Meeting
    • Place of Presentation
      Boston
    • Year and Date
      2008-05-29
    • Related Report
      2008 Annual Research Report
  • [Presentation] 新しい造血因子探索を目的としたヒト胎児肝レンチウイルス発現ライブラリーの構築2007

    • Author(s)
      栗田良、末廣陽子、谷憲三朗
    • Organizer
      第69回日本血液学会
    • Place of Presentation
      横浜
    • Related Report
      2007 Annual Research Report
  • [Presentation] Construction of a high performance lentiviral cDNA library derived fromhuman fetal liver2007

    • Author(s)
      Kurita, R.・Tani, K., et. al.
    • Organizer
      American Society of Gene Therapy(
    • Place of Presentation
      Seattle
    • Related Report
      2007 Annual Research Report
  • [Presentation] Non-transmissible SeV encoding murine GM-CSF, another potent vector system to produce antologous tumor vaccines2007

    • Author(s)
      Inoue, H.・Tani, K., et. al.
    • Organizer
      American Society of Gene Therapy
    • Place of Presentation
      Seattle
    • Related Report
      2007 Annual Research Report
  • [Presentation] TARC and RANTES enhance immunological antitumor effect induced byGM-CSFtransduced leukemia vaccine in mouse model.2007

    • Author(s)
      Inoue, H.・Iga, M.・Tani, K., et. al.
    • Organizer
      American Society of Hematology
    • Place of Presentation
      Atlanta
    • Related Report
      2007 Annual Research Report
  • [Presentation] IN VIVO ANTIIUMOR VACCINE EFFECTS OF NON-TRANSMISSIBLE SeVENCODING GM-CSF IN MOUSE RENAL CELL CARCINOMA MODELS.2007

    • Author(s)
      Inoue, H.・Kurita, R.・Tani., K., et. al.
    • Organizer
      日本遺伝子治療学会
    • Place of Presentation
      愛知県立がんセンター
    • Related Report
      2007 Annual Research Report
  • [Presentation] Non-transmissible SeV(dF)-transduced autologous GM-CSF cancer vaccine cells as a candidate for immune gene therapy.2007

    • Author(s)
      Inoue, H.・Hurita, R.・Tani., K., et. al.
    • Organizer
      日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜
    • Related Report
      2007 Annual Research Report
  • [Book] 分子細胞治療(悪性腫瘍に対する遺伝子治療, 8(6))2009

    • Author(s)
      谷憲三朗
    • Related Report
      2009 Final Research Report
  • [Book] 最新医学(コモンマーモセット, 64)2009

    • Author(s)
      谷憲三朗
    • Related Report
      2009 Final Research Report
  • [Book] 日本医師会雑誌(遺伝子治療, 138)2009

    • Author(s)
      谷憲三朗
    • Related Report
      2009 Final Research Report
  • [Book] 日本医師会雑誌(遺伝子治療)2009

    • Author(s)
      谷憲三朗
    • Total Pages
      3
    • Related Report
      2009 Annual Research Report
  • [Book] 細胞療法 : その現状とトランスレーショナルリサーチからの今後の展望2008

    • Author(s)
      谷憲三朗
    • Total Pages
      115
    • Publisher
      医薬ジャーナル社
    • Related Report
      2008 Annual Research Report
  • [Book] 遺伝子治療領域における細胞療法の現状2007

    • Author(s)
      谷 憲三朗
    • Publisher
      医薬ジャーナル社
    • Related Report
      2007 Annual Research Report
  • [Book] 細胞療法:その現状とトランスレーショナルリサーチからの今後の展望2007

    • Author(s)
      谷 憲三朗
    • Publisher
      医薬ジャーナル社
    • Related Report
      2007 Annual Research Report
  • [Book] 遺伝子療法領域におけるトランスレーショナルリサーチFrontiers in Gastroenterology2007

    • Author(s)
      谷 憲三朗
    • Total Pages
      97
    • Publisher
      (株)メディカルレビュー社
    • Related Report
      2006 Annual Research Report
  • [Book] 最新医学・第61巻・第6号 がん領域におけるドラッグデリバリーシステム(DDS)DDSと細胞療法2006

    • Author(s)
      中村 貴文, 谷 憲三朗
    • Total Pages
      162
    • Publisher
      最新医学社
    • Related Report
      2006 Annual Research Report
  • [Book] 癌治療の新たな試み(新編III)2005

    • Author(s)
      谷 憲三朗
    • Total Pages
      798
    • Publisher
      医薬ジャーナル社(西條 長宏編)
    • Related Report
      2005 Annual Research Report
  • [Patent(Industrial Property Rights)] NOVEL ONCOLYTIC VIRUS FOR LUNG CANCER2010

    • Inventor(s)
      谷憲三朗
    • Filing Date
      2010
    • Related Report
      2009 Final Research Report
  • [Patent(Industrial Property Rights)] NOVEL ERYTHROCYTE DIFFERENTIATION INDUCING METHOD AND NOVEL ERYTHROCYTE DIFFERENTIATION MARKER2010

    • Inventor(s)
      谷憲三朗, 横尾朋子
    • Industrial Property Rights Holder
      九州大学
    • Filing Date
      2010-03-04
    • Related Report
      2009 Annual Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] 遺伝子治療用ウイルスベクター2008

    • Inventor(s)
      谷憲三朗, 他4名
    • Industrial Property Rights Holder
      谷憲三朗, 他4名
    • Filing Date
      2008-04-25
    • Related Report
      2008 Annual Research Report
  • [Patent(Industrial Property Rights)] Methods for acceleration of stem cell differentiation2006

    • Inventor(s)
      Tani, K. et al.
    • Industrial Property Rights Holder
      Tani, K. et al.
    • Filing Date
      2006-03-15
    • Related Report
      2006 Annual Research Report
  • [Patent(Industrial Property Rights)] 腫瘍マーカーとしての抗NASP抗体及び抗TMF抗体2005

    • Inventor(s)
      谷憲三朗他3名
    • Industrial Property Rights Holder
      谷憲三朗他3名
    • Patent Publication Number
      2006-242869
    • Filing Date
      2005-03-04
    • Acquisition Date
      2006-09-14
    • Related Report
      2006 Annual Research Report
  • [Patent(Industrial Property Rights)] 腫瘍マーカーとしての抗NASP抗体及び抗TMF抗体2005

    • Inventor(s)
      谷 憲三朗 他3人
    • Industrial Property Rights Holder
      谷 憲三朗 他3人
    • Industrial Property Number
      2005-061605
    • Filing Date
      2005-03-04
    • Related Report
      2005 Annual Research Report
  • [Patent(Industrial Property Rights)] THERAPEUTIC AGENT FOR MALIGNANT TUMOR USING ONCOLYTIC MEASLES VIRUS, AND THERAPEUTIC METHOD USING THE AGENT

    • Inventor(s)
      谷憲三朗
    • Related Report
      2009 Final Research Report

URL: 

Published: 2005-04-01   Modified: 2018-03-28  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi